Multi-centre, Randomised, Double-blind, Parallel-group Study to Compare Efficacy and Safety Between Anastrozole (ZD1033) and Tamoxifen in Pre- and Post-operative Administration Under Goserelin Acetate Treatment for Premenopausal Breast Cancer Patients.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Anastrozole (Primary) ; Goserelin; Tamoxifen
- Indications Early breast cancer; HER2 negative breast cancer
- Focus Biomarker; Registrational; Therapeutic Use
- Acronyms STAGE
- Sponsors AstraZeneca
- 12 Sep 2012 Results of an exploratory analysis of Ki-67 expression published in Cancer.
- 19 Jan 2012 Results published in Lancet Oncology.
- 07 Jun 2011 Results of an analysis on the Ki67 index presented at the 47th Annual Meeting of the American Society of Clinical Oncology.